CSI Market
Sign In | Register

Abiomed Inc (ABMD) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ABMD quarterly Cash Flow →
Reviewing cash flow figures over time highlights how Abiomed Inc balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Mar 31 2022)
12 Months 		(Mar 31 2021) (Mar 31 2020) (Mar 31 2019) (Mar 31 2018)
Operating Activities
Income136.51
Depreciation & amortization28.09
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability-0.86
Provision For Loan Losses Expensed0.05
Inventories Decrease /-Increase-11.33
Research and Development in Process115.99
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation52.73
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Increase Decrease In Contract With Customer Liability2.32
Income taxes5.30
Gain on Sale of Investments-20.98
Increase (Decrease) in Accounts Receivable5.34
Increase (Decrease) in Accounts Payable0.64
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-0.76
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-8.41
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-19.22
Discontinued operations0.00
Net Cash flow from Operating Activities285.39
Investing Activities
Capital Expenditures-35.76
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities-787.15
Real Estate Investments0.00
Proceeds From Payments For Sale Of Subsidiary Stock-
Proceeds From Sale And Maturity Of Marketable Securities And Other543.51
Payments To Acquire Other Investments And Intangible Assets-18.77
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale of Investment Projects0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-82.82
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-380.99
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock16.66
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-18.34
Proceeds From Issuance Of Common Stock Under Employee Stock Plans-
Capital Expenditures Incurred But Not Yet Paid1.82
Stock Issued-
Proceeds Or Payments For Issuance Or Repurchase Of Common Stock Net-
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements-2.33
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-2.20
Effect of exchange rate on cash flow-2.09
Discontinued operations0.00
Free Cash Flow249.63
Total Cash Flow-99.89
4 historic quarters locked

Sign in to unlock the full Abiomed Inc cash flow history.

Sign In Create Free Account

About Abiomed Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-22-021880

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License